Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Ceska

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Nature Communications|January 26, 2021
A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNFDaniel J Lightwood, Rebecca J Munro, John Porter, et al.
Nature Communications|December 21, 2019
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimerJames O'Connell, John Porter, Boris Kroeplien, et al.
The Journal of Biological Chemistry|April 26, 2017
Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumabAnna M Davies, Elizabeth G Allan, Anthony H Keeble, et al.
Nature|November 19, 2013
Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin ARoger M Benoit, Daniel Frey, Manuel Hilbert, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2008
Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazinesBenjamin Perry, Rikki Alexander, Gavin Bennett, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 17, 2015
GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014Alexander Heifetz, Gebhard F X Schertler, Roland Seifert, et al.
Chemmedchem|February 8, 2014
Binding mode and structure-activity relationships around direct inhibitors of the Nrf2-Keap1 complexEric Jnoff, Claudia Albrecht, John J Barker, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2007
Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitorsMahbub Alam, Rebekah E Beevers, Tom Ceska, et al.
Journal of Medicinal Chemistry|June 29, 2018
Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in VivoJames Reuberson, Helen Horsley, Richard J Franklin, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Nature Communications|January 26, 2021
A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNFDaniel J Lightwood, Rebecca J Munro, John Porter, et al.
Nature Communications|December 21, 2019
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimerJames O'Connell, John Porter, Boris Kroeplien, et al.
The Journal of Biological Chemistry|April 26, 2017
Allosteric mechanism of action of the therapeutic anti-IgE antibody omalizumabAnna M Davies, Elizabeth G Allan, Anthony H Keeble, et al.
Nature|November 19, 2013
Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin ARoger M Benoit, Daniel Frey, Manuel Hilbert, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2008
Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazinesBenjamin Perry, Rikki Alexander, Gavin Bennett, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 17, 2015
GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014Alexander Heifetz, Gebhard F X Schertler, Roland Seifert, et al.
Chemmedchem|February 8, 2014
Binding mode and structure-activity relationships around direct inhibitors of the Nrf2-Keap1 complexEric Jnoff, Claudia Albrecht, John J Barker, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2007
Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitorsMahbub Alam, Rebekah E Beevers, Tom Ceska, et al.
Journal of Medicinal Chemistry|June 29, 2018
Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in VivoJames Reuberson, Helen Horsley, Richard J Franklin, et al.
Pageof 2